Table 1. Demographic and clinical characteristics of those surveyed in this study

 

 

Heard of HZ Vaccine

n = 419, (%)

Not heard of HZ Vaccine

n = 581, (%)

P-Value; Odds Ratio [95% Confidence Interval]

Gender

 

 

 

P = 0.001

 

Male

40.2

58.0

 

 

 

 

Female

59.8

42.0

 

 

 

Age Group

 

 

 

 

 

 

 

50-59

12.3

33.1

 

 

 

 

60-69

23.0

23.1

 

 

 

 

≥70

64.8

43.8

≥70 years v. all other age groups:
P = 0.0001; 2.5 [1.55-4.05]

Ethnicity

 

 

 

 

 

 

 

Caucasian

93.4

89.9

 

 

 

 

Hispanic

2.5

6.5

Hispanic v. all other ethnicities
P = 0.04; 0.33 [0.19-1.95]

 

Black

4.1

1.8

 

 

 

 

Other

0

1.8

 

 

 

Highest level of Education

 

 

 

 

 

 

Grade school

0

2.8

 

 

 

 

Middle school

3.3

5.6

 

 

 

 

High school

33.6

45.5

 

 

 

 

College

47.5

36.1

College & post graduate v. all other education levels.  P = 0.0003; 1.96 [1.55-4.52]

 

Post graduate

15.6

10.0

 

 

 

Employment Status

 

 

 

 

 

 

Yes

21.3

40.8

 

 

 

 

No

16.4

10.1

 

 

 

 

Retired

62.3

49.1

Retired v. all other employment statuses:
P = .026; 1.70 [1.06-2.75]

Have health insurance

99.2

97.6

P = 0.37

Visited PCP in the past year

93.4

90.5

P = 0.33

Remember chicken pox

86.1

76.9

P = 0.05; 1.84 [1.39-3.52]

Heard of shingles

95.1

82.8

P = 0.0015; 3.99 [1.66-10.87]

Had shingles

29.5

17.8

P = 0.018; 1.93 [1.11-3.39]

Have blood relatives with shingles

32.8

30.2

P = 0.63

Have friends and/or spouse with shingles

53.0

32.4

P = 0.008; 1.90 [1.17-3.09]

Received influenza vaccine in the past year

64.8

47.3

P = 0.0031; 2.04 [1.26-3.31]

Reported adverse reaction to vaccine in the past

9.0

6.5

P = 0.42

Informed of recent FDA approval of HZ Vaccine

for adults ≥50 years of age

36.1

 

 

Received HZ Vaccine

28.7

-

 

Heard of HZ Vaccine from:

 

 

 

 

PCP

28.7

-

 

 

Dermatologist

15.6

-

 

 

Pharmacy

4.1

-

 

 

News

34.4

-

 

 

Other

17.2

-